Health-related quality of life in relation to fatigue, depression, anxiety, and disease manifestations in systemic lupus erythematosus and vasculitis
Rheumatology Advances in Practice · 2026-11-10
DOI: 10.1093/rap/rkag144 ↗Abstract
Abstract Objectives We explored health-related quality of life (HRQoL) in relation to fatigue, depression, anxiety, and disease characteristics in people with ANCA-associated vasculitis (AAV) and Systemic Lupus Erythematosus (SLE). Methods In this cross-sectional study, patient-reported outcome measures included HRQoL (EQ-5D-3L), fatigue (Multidimensional Assessment of Fatigue), and anxiety and depression (Hospital Anxiety and Depression Scale). Physicians assessed disease activity and characteristics. Group comparisons used chi-square and Mann–Whitney U tests. Multivariable linear regression models identified determinants of HRQoL. Results We included 481 individuals with SLE, 256 with AAV, and 125 controls. Individuals with AAV and SLE experienced reduced HRQoL, greater fatigue, and higher levels of anxiety and depression compared to controls, but no differences were found between SLE and AAV. In combined SLE/AAV analyses, active organ involvement (skin, lungs, kidneys), was associated with lower HRQoL and more fatigue. In linear regression, including physical, social, and disease-specific aspects (Model A), active disease and older age were associated with lower HRQoL, while being male and cohabitation were associated with higher HRQoL. The adjusted R² value indicated that Model A explained 12.1% of the variance in HRQoL. After adding psychological aspects, fatigue, depression, and anxiety (Model B), the adjusted R² value indicated that the model explained 35.9% of the variance, increasing the proportion of HRQoL variance explained. Conclusion Across SLE and AAV diagnoses, active organ involvement in skin, lungs and kidneys was associated with lower HRQoL and more fatigue. Furthermore, combining disease characteristics with psychological aspects increased the explanatory determinants of HRQoL in both diseases.
EUVIMED